Tocqueville Asset Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Tocqueville Asset Management’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-28,600	Closed	-$327K	–	886
2016 Q3	$327K	Hold	28,600	–	–	﹤0.01%	696
2016 Q2	$352K	Sell	28,600 -2,600	-8%	-$31.5K	﹤0.01%	695
2016 Q1	$315K	Sell	31,200 -26,050	-46%	-$306K	﹤0.01%	719
2015 Q4	$1.29M	Buy	57,250 +21,400	+60%	+$438K	0.02%	496
2015 Q3	$595K	Sell	35,850 -5,400	-13%	-$108K	0.01%	657
2015 Q2	$928K	Sell	41,250 -2,100	-5%	-$51.8K	0.01%	585
2015 Q1	$1.12M	Hold	43,350	–	–	0.01%	569
2014 Q4	$943K	Buy	43,350 +1,000	+2%	+$20.5K	0.01%	594
2014 Q3	$802K	Sell	42,350 -800	-2%	-$16.1K	0.01%	536
2014 Q2	$1M	Buy	43,150 +17,250	+67%	+$426K	0.01%	575
2014 Q1	$872K	Buy	25,900 +16,500	+176%	+$556K	0.01%	472
2013 Q4	$277K	Buy	+9,400	New	+$172K	﹤0.01%	729

Other funds holding OMED

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tocqueville Asset Management's OMED Position: Q4 2016 in Review

Tocqueville Asset Management sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q4 2016, closing a stake of 28,600 shares — an estimated $327K sold.

Tocqueville Asset Management first reported a position in OMED in Q4 2013 and held it in 12 quarters. The position peaked at $1.29M in Q4 2015. 86 funds tracked by Wall St. Rank hold OMED as of Q4 2016.

Tocqueville Asset Management reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Tocqueville Asset Management sold 28,600 OncoMed Pharmaceuticals, Inc. shares in Q4 2016, an estimated $327K.
Tocqueville Asset Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2013 and held it in 12 quarters.
Tocqueville Asset Management's OncoMed Pharmaceuticals, Inc. position peaked at $1.29M in Q4 2015.
86 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q4 2016.

Based on Tocqueville Asset Management's 13F filing for Q4 2016, filed 30 Jan 2017.